Fri, 27 Mar 2020 13:45:58: Preventing Type 1 diabetes by deleting a stress response gene

Fri, 27 Mar 2020 12:32:49: Vertex guns for virtual trials but hits pause, sees delays for 'some new study starts'

Fri, 27 Mar 2020 11:09:24: Big Pharma companies join forces for fightback against COVID-19

Fri, 27 Mar 2020 10:21:55: FDA moots virtual AdComms but delays GSK, Intercept meetings

Fri, 27 Mar 2020 08:36:47: In conversation with: Science 37 and the response to COVID-19

Fri, 27 Mar 2020 08:15:43: U.K. government-backed medical research shut down amid COVID-19

Thu, 26 Mar 2020 13:08:20: COVID-19 prompts Pfizer to stop enrollment in most studies

Thu, 26 Mar 2020 13:04:44: Safely overcoming resistance to checkpoint inhibition in cancer by blocking a growth factor

Thu, 26 Mar 2020 12:59:03: Chutes & Ladders—Urovant brings on Astellas alum Robinson as CEO

Thu, 26 Mar 2020 12:32:47: Ipsen scraps pivotal trial as partial clinical hold drags on

Thu, 26 Mar 2020 08:57:14: Cancer biotech Viracta nabs Nordic Nanovector exec as CMO

Wed, 25 Mar 2020 19:03:44: Roche forges antibiotics pact as it sees beyond COVID-19 threats to public health

Wed, 25 Mar 2020 18:01:29: PRA Health Sciences unveils COVID-19 monitoring app to track symptoms

Wed, 25 Mar 2020 12:39:07: Scangos' Vir Biotechnology to test COVID-19 antibody 'in the summer'

Wed, 25 Mar 2020 10:40:23: Astra, Daiichi's Enhertu shows early promise in HER2 lung cancer

Wed, 25 Mar 2020 10:13:04: China biotech Laekna snaps up Novartis PD-L1 cancer therapy

Wed, 25 Mar 2020 09:55:10: AstraZeneca pays Silence $60M to take siRNA beyond the liver

Wed, 25 Mar 2020 07:41:29: Redpin bags A round to advance Chantix-controlled gene therapies

Tue, 24 Mar 2020 12:42:42: Novavax flu vaccine matches and beats Sanofi rival in phase 3

Tue, 24 Mar 2020 10:57:55: Embattled Cel-Sci to tackle COVID-19 with immunotherapy platform tech LEAPS

Tue, 24 Mar 2020 10:50:22: CytomX pens $1.6B Astellas biobucks pact for T-cell R&D

Tue, 24 Mar 2020 08:24:48: U.K. gov backs push to start COVID-19 vaccine trial in April

Mon, 23 Mar 2020 13:16:50: AlloVir, Baylor ally to develop COVID-19 T-cell therapy

Mon, 23 Mar 2020 13:09:08: AbbVie-backed Carisma's 'CAR-M' tech shrinks tumors in mouse models of ovarian cancer

Mon, 23 Mar 2020 11:50:19: Lilly slashes clinical trial activities in response to COVID-19